References
cardiac arrest
CARDIAC ARREST, SENSITIVITY
eTable 1. Demographic characteristic of the discovery cohorteTable 2. Serum p-tau, Aβ40, Aβ42 and Aβ42/40 in out-of-hospital cardiac arrest with good and poor neurologic outcome (discovery cohort)eTable 3. Summary statistics of the longitudinal analysis in the validation cohorteTable 4. Biomarker fold changes at each time point in the validation cohorteTable 5. Sensitivity analysis: serum p-tau, t-tau, NfL, Aβ40, Aβ42 and Aβ42/40 in cardiac arrest with good and poor outcome (validation cohort – complete cases)eTable 6. Sensitivity analysis: summary statistics of the longitudinal analyses in the validation cohort on complete caseseTable 7. Sensitivity analysis: biomarker fold changes at each time point in the validation cohort on complete caseseFigure 1. Cross-sectional biomarker concentrations in the discovery cohorteFigure 2. Biomarker changes over time in the discovery cohorteFigure 3. Cross-sectional biomarker concentrations in the validation cohorteFigure 4. Biomarker correlations in the validation cohorteFigure 5. Biomarker change correlations in the validation cohorteFigure 6. Sensitivity analysis: fold-changes of blood levels of p-tau, NfL, t-tau, Aβ40, Aβ42 and AB42/40Click here for additional data file.Data sharing statementClick here for additional data file.